Niagen Bioscience, Inc.
NAGE
$9.88
-$0.16-1.59%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 117.51% | 102.33% | 63.79% | 21.13% | 5.63% |
| Total Receivables | 17.64% | 5.97% | 65.61% | 42.76% | 42.50% |
| Inventory | 25.15% | -10.48% | -36.72% | -16.48% | -3.86% |
| Prepaid Expenses | 29.88% | 3.75% | -35.43% | -45.21% | -36.98% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Current Assets | 75.81% | 55.62% | 29.41% | 10.50% | 6.30% |
|
|
|||||
| Total Current Assets | 75.81% | 55.62% | 29.41% | 10.50% | 6.30% |
| Net Property, Plant & Equipment | 6.48% | 2.67% | -23.98% | -31.70% | -31.27% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -34.71% | -31.78% | -29.61% | -28.08% | -26.40% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.79% | 13.09% | -3.92% | -17.62% | -23.94% |
| Total Assets | 69.38% | 50.40% | 24.22% | 5.68% | 1.62% |
|
|
|||||
| Total Accounts Payable | 68.78% | 34.60% | -16.67% | -24.95% | -19.20% |
| Total Accrued Expenses | -14.38% | -13.52% | -17.66% | 4.34% | 6.71% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -2.23% | 10.10% | 41.60% | 18.06% | 25.48% |
| Total Finance Division Other Current Liabilities | 94.23% | -8.81% | 213.33% | -2.65% | -6.02% |
| Total Other Current Liabilities | 94.23% | -8.81% | 213.33% | -2.65% | -6.02% |
| Total Current Liabilities | 24.96% | 7.12% | -12.97% | -8.97% | -6.26% |
|
|
|||||
| Total Current Liabilities | 24.96% | 7.12% | -12.97% | -8.97% | -6.26% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 8.88% | 8.92% | -35.65% | -35.90% | -32.18% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -19.24% | -22.11% | -22.11% | -32.24% | -13.01% |
| Total Liabilities | 17.21% | 3.44% | -16.31% | -15.37% | -10.39% |
|
|
|||||
| Common Stock & APIC | 7.10% | 5.59% | 4.15% | 2.56% | 2.27% |
| Retained Earnings | 9.28% | 7.39% | 4.49% | 0.78% | -0.71% |
| Treasury Stock & Other | -100.00% | -400.00% | 0.00% | -600.00% | -100.00% |
| Total Common Equity | 108.98% | 91.17% | 61.98% | 25.86% | 13.14% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 108.98% | 91.17% | 61.98% | 25.86% | 13.14% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 108.98% | 91.17% | 61.98% | 25.86% | 13.14% |
|
|
|||||